跳至主要内容
临床试验/NL-OMON47450
NL-OMON47450已完成不适用

Controlled hypotensive versus massive fluid resuscitation strategy: influence on blood loss and hemostatic parameters in obstetric hemorrhage - Resuscitation strategy in obstetric hemorrhage

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 251 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Pregnant women attending the outpatient clinic
  • - Pregnant and delivery/labor, > 24 weeks
  • - Age >= 18 years
  • - Informed consent
  • - Mentally competent, understanding Dutch language

排除标准

  • - Labor < 24+0 weeks
  • -Prophylactic or therapeutic anticoagulant therapy (carbasalate calcium within the last 10 days or low molecular weight heparins within last 48 hours)
  • - Known congenital, coagulation disorders
  • - Pre-eclampsia
  • - Known contra-indications for liberal fluid management
  • - Proven placenta accreta/percreta or increta;In principle there are no circumstances in which women will be excluded after the study protocol has started. We will use an intention to treat analysis, so there will be no post-randomisation exclusions. In women with more than 1500 cc of blood loss the protocol massive blood loss will be followed. At that point the endpoint of the study intervention has been reached.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验